Mark Gavin Lotter

Mark Gavin Lotter

Directeur Général chez
Nuance Pharma (Shanghai) Co., Ltd.
64 ans
Health Technology
Consumer Services

Profil

Mark Gavin Lotter is the founder of NovaMed Pharmaceuticals, Inc. (founded in 2005) and Nuance Pharma (Shanghai) Co., Ltd. (founded in 2014).
At NovaMed Pharmaceuticals, he held the titles of President & Chief Executive Officer from 2006 to 2010.
At Nuance Pharma (Shanghai) Co., Ltd., he is currently the Chief Executive Officer.
Mr. Lotter's former jobs include Director & CEO-China Operations at SciClone Pharmaceuticals LLC from 2011 to 2012, Chief Executive Officer at Aspen Pharmacare Holdings Ltd., Vice President-Operations at AstraZeneca Pharmaceuticals LP, and Independent Non-Executive Director at China Health Group, Inc. from 2015 to 2019.
Mr. Lotter received his undergraduate degree from the University of Natal and his MBA from the University of South Africa.

Postes actifs de Mark Gavin Lotter

SociétésPosteDébut
Directeur Général 12/08/2014

Anciens postes connus de Mark Gavin Lotter

SociétésPosteFin
CHINA HEALTH GROUP INC. Directeur/Membre du Conseil 20/06/2019
SCICLONE PHARMACEUTICALS, INC. Directeur/Membre du Conseil 14/12/2012
Fondateur 18/04/2011
ASPEN PHARMACARE HOLDINGS LIMITED Directeur Général -
Directeur des opérations -
Voir l'expérience en détail de Mark Gavin Lotter

Formation de Mark Gavin Lotter

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Gavin Lotter
🔇